GV Prasad, Co-Chairman & MD, Dr Reddy’s Lab said Canada could offer early market opportunity before competition increases. The company plans launches in multiple markets based on patent and approval status. Dr Reddy’s is focusing on partnerships, biosimilars pipeline expansion and selective global acquisitions to support long-term growth.
